BD HorizonTM V500 Mouse anti-Human HLA-DR

Description

Flow cytometric analysis of HLA-DR expressed on human lymphocytes. Whole blood was stained with BD Horizon V500 Mouse anti-Human HLA-DR antibody Cat. No. 561224/561225; solid line histogram or with a BD Horizon V500 Mouse IgG2a, kappa Isotype control Cat. No. 561221; dotted line histogram . The erythrocytes were lysed with BD PharmLyse Lysing Buffer Cat. No. 555899 . The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD FACSCanto II Flow Cytometer System. Flow cytometric analysis of HLA-DR expressed on human lymphocytes. Whole blood was stained with BD Horizon V500 Mouse anti-Human HLA-DR antibody Cat. No. 561224/561225; solid line histogram or with a BD Horizon V500 Mouse IgG2a, kappa Isotype control Cat. No. 561221; dotted line histogram . The erythrocytes were lysed with BD PharmLyse Lysing Buffer Cat. No. 555899 . The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD FACSCanto II Flow Cytometer System. Show More Flow cytometric analysis of HLA-DR expressed on human lymphocytes. Whole blood was stained with BD Horizon V500 Mouse anti-Human HLA-DR antibody Cat. No. 561224/561225; solid line histogram or with a BD Horizon V500 Mouse IgG2a, kappa Isotype control Cat. No. 561221; dotted line histogram . The erythrocytes were lysed with BD PharmLyse Lysing Buffer Cat. No. 555899 . The fluorescence histograms were derived from events with the forward and side light-scatter characteristics of viable lymphocytes. Flow cytometry was performed using a BD FACSCanto II Flow Cytometer System.